FindTrial
Sign In

Body Composition Monitoring

DEVICE5 trials

Sponsors

Medical University of Vienna, Grigore T. Popa University of Medicine and Pharmacy, Rainer Oberbauer

Conditions

Acute Myocardial InfarctionBody Fluid CompartmentsChronic Kidney Disease Requiring Chronic DialysisDehydrationFluid OverloadFluid ShiftsHypertension, RenovascularLeft Ventricular Hypertrophy

Phase 4

Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients
CompletedNCT03182699
Rainer OberbauerChronic Kidney Disease Requiring Chronic Dialysis, Left Ventricular Hypertrophy, Secondary Hyperparathyroidism
Start: 2017-10-01End: 2019-12-20Updated: 2020-06-09

Unknown Phase

Body Composition Monitoring(BCM) for Determination of the Fluid Status in Patients Undergoing General Anesthesia
CompletedNCT01945541
Medical University of ViennaFluid Overload
Start: 2013-08-31End: 2016-08-24Updated: 2020-07-14
Body Composition Monitoring for Determination of the Fluid Status in Volunteers Undergoing Intravenous Fluid Therapy
CompletedNCT02296294
Medical University of ViennaBody Fluid Compartments, Fluid Shifts
Start: 2014-10-31End: 2016-07-31Updated: 2016-07-14
Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)
NCT02388139
Grigore T. Popa University of Medicine and PharmacyHypertension, Renovascular, Myocardial Infarction, Renal Artery Stenosis
Start: 2014-10-31End: 2017-06-30Target: 200Updated: 2016-01-13
Hydration Status Assessment Through Body Composition Monitoring in Patients With Acute Myocardial Infarction
NCT02655341
Grigore T. Popa University of Medicine and PharmacyAcute Myocardial Infarction, Dehydration, Renal Artery Stenosis
Start: 2016-01-31End: 2018-01-31Target: 400Updated: 2016-01-14

Related Papers

Effect of etelcalcetide versus alfacalcidol on left ventricular function and feature-tracking cardiac magnetic resonance imaging in hemodialysis-a post-hoc analysis of a randomized, controlled trial.
2023-11-062 citations
Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study
Frontiers in Medicine2022-07-065 citations
The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis
Frontiers in Medicine2022-04-266 citations
Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis
Circulation Research2021-04-0749 citations
Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD)
Trials2019-10-2412 citations
Atherosclerotic Renal Artery Stenosis Prevalence and Correlations in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Interventions: Data From Nonrandomized Single‐Center Study (REN‐ACS)—A Single Center, Prospective, Observational Study
Journal of the American Heart Association2015-10-1320 citations